Ginna Laport
Hoofd Techniek/Wetenschap/O&O bij CARGO THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Profiel
Ginna G.
Laport is currently the Chief Medical Officer at Cargo Therapeutics, Inc. She previously held positions as the National Chairman at Blood & Marrow Transplant Clinical Trials Network, Vice President-Clinical Development at Genentech, Inc., Vice President-Clinical Development at Corvus Pharmaceuticals, Inc., Assistant Professor at the University of Pennsylvania, and Professor at Stanford University School of Medicine.
She also served as the Chief Medical Officer at Tempest Therapeutics, Inc. Dr. Laport completed her undergraduate degree at Baylor University and her doctorate at The University of Texas at Austin.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CARGO THERAPEUTICS, INC.
-.--% | 05-04-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Ginna Laport
| Bedrijven | Functie | Begin |
|---|---|---|
| CARGO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 17-10-2023 |
Eerdere bekende functies van Ginna Laport
| Bedrijven | Functie | Einde |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Hoofd Techniek/Wetenschap/O&O | 01-10-2023 |
| TEMPEST THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-10-2019 |
| CORVUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-09-2018 |
| Stanford University School of Medicine | Corporate Officer/Principal | 01-10-2015 |
| University of Pennsylvania | Corporate Officer/Principal | 01-01-2001 |
Opleiding van Ginna Laport
| Baylor University | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| CORVUS PHARMACEUTICALS, INC. | Health Technology |
| TEMPEST THERAPEUTICS, INC. | Health Technology |
| CARGO THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Blood & Marrow Transplant Clinical Trials Network |
